NasdaqGS - Delayed Quote USD

Recursion Pharmaceuticals, Inc. (RXRX)

Compare
6.32 -0.36 (-5.39%)
At close: October 31 at 4:00 PM EDT
6.40 +0.08 (+1.27%)
Pre-Market: 7:00 AM EDT
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
653,699.00
701,288.00
610,345.00
298,585.00
Total Liabilities Net Minority Interest
190,263.00
215,482.00
67,407.00
504,874.00
Total Equity Gross Minority Interest
463,436.00
485,806.00
542,938.00
-206,289.00
Total Capitalization
464,537.00
486,342.00
543,571.00
-194,875.00
Common Stock Equity
463,436.00
485,806.00
542,938.00
-206,289.00
Capital Lease Obligations
49,530.00
50,372.00
10,755.00
3,175.00
Net Tangible Assets
374,937.00
483,699.00
540,752.00
-208,779.00
Working Capital
344,966.00
469,549.00
488,060.00
243,338.00
Invested Capital
464,578.00
486,439.00
543,661.00
-193,802.00
Tangible Book Value
374,937.00
483,699.00
540,752.00
-208,779.00
Total Debt
50,672.00
51,005.00
11,478.00
15,662.00
Share Issued
233,809.64
191,022.86
170,272.46
155,912.70
Ordinary Shares Number
233,809.64
191,022.86
170,272.46
155,912.70
12/31/2020 - 4/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers